Trial · NCT03274895
Adverse events28
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 28
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | eye pain | Eye disorders | PHMB 0.08% Plus Placebo | 9 | 69 | 11 |
| other | eye pain | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 7 | 65 | 7 |
| other | ocular hyperemia | Eye disorders | PHMB 0.08% Plus Placebo | 8 | 69 | 9 |
| other | ocular hyperemia | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 7 | 65 | 9 |
| other | lacrimation increased | Eye disorders | PHMB 0.08% Plus Placebo | 6 | 69 | 6 |
| other | lacrimation increased | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 2 | 65 | 2 |
| other | conjunctival hyperemia | Eye disorders | PHMB 0.08% Plus Placebo | 2 | 69 | 2 |
| other | conjunctival hyperemia | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 3 | 65 | 4 |
| other | eye irritation | Eye disorders | PHMB 0.08% Plus Placebo | 1 | 69 | 1 |
| other | eye irritation | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 4 | 65 | 4 |
| other | photophobia | Eye disorders | PHMB 0.08% Plus Placebo | 2 | 69 | 2 |
| other | photophobia | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 3 | 65 | 3 |
| other | eye inflammation | Eye disorders | PHMB 0.08% Plus Placebo | 3 | 69 | 3 |
| other | eye inflammation | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 1 | 65 | 3 |
| other | corneal epithelium defect | Eye disorders | PHMB 0.08% Plus Placebo | 3 | 69 | 3 |
| other | corneal epithelium defect | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 0 | 65 | 0 |
| other | corneal infiltrates | Eye disorders | PHMB 0.08% Plus Placebo | 3 | 69 | 3 |
| other | corneal infiltrates | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 0 | 65 | 0 |
| other | eye pruritus | Eye disorders | PHMB 0.08% Plus Placebo | 1 | 69 | 1 |
| other | eye pruritus | Eye disorders | PHMB 0.02% Plus Propamidine 0.1% | 2 | 65 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03274895/events